Get started
Author

Charles Shale

Observed names: C. Shale, Shale, Charles
Observed institution: Hartwig Medical Foundation
ORCID: 0000-0002-4226-0252
Observed ORCID: 0000-0002-4226-0252
OpenAlex ID: A5026275940
Pan-cancer whole-genome analyses of metastatic solid tumours
2019 · Peter Priestley, Jonathan Baber, et al. · Nature · 1,140
PDF
GRIDSS2: comprehensive characterisation of somatic structural variation using single breakend variants and structural variant phasing
2021 · Daniel L. Cameron, Jonathan Baber, et al. · Genome biology · 192
PDF
Genetic immune escape landscape in primary and metastatic cancer
2023 · Francisco Martínez-Jiménez, Peter Priestley, et al. · Nature Genetics · 116
PDF
Unscrambling cancer genomes via integrated analysis of structural variation and copy number
2022 · Charles Shale, Daniel L. Cameron, et al. · Cell Genomics · 86
PDF
GRIDSS, PURPLE, LINX: Unscrambling the tumor genome via integrated analysis of structural variation and copy number
2019 · Daniel L. Cameron, Jonathan Baber, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 61
PDF
Complete genomic characterization in patients with cancer of unknown primary origin in routine diagnostics
2022 · L.J. Schipper, K.G. Samsom, et al. · ESMO Open · 42
PDF
Whole genome sequencing improves tissue-of-origin diagnosis and treatment options for cancer of unknown primary
2025 · Richard J. Rebello, Atara Posner, et al. · Nature Communications · 20
PDF
GRIDSS2: comprehensive characterisation of somatic structural variation using single breakend variants and structural variant phasing
2020 · Daniel L. Cameron, Jonathan Baber, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 12
PDF
Recurrent exon-deleting activating mutations in AHR act as drivers of urinary tract cancer
2022 · Judith M. Vlaar, Anouska Borgman, et al. · Scientific Reports · 6
PDF
Abstract A045 Implementing ultra-sensitive, ctDNA-based liquid biopsy for disease monitoring in paediatric tumours
2024 · Robert Salomon, Wenhan Chen, et al. · Cancer Research · 1
1133P Whole genome sequencing can classify diagnostically challenging tumors
2021 · L.J. Schipper, P. Snaebjornsson, et al. · Annals of Oncology · 1
ID #736 Ultra-sensitive plasma ctDNA assay enables detection of brain tumour DNA in peripheral blood and is prognostic in childhood brain cancer
2026 · Marion Mateos, Neevika Manoharan, et al. · Neuro-Oncology Pediatrics
Abstract A002-PR011: Precision Diagnosis in High-Risk Pediatric Oncology through Integrated Whole Genome, Transcriptome, and Epigenome Profiling
2025 · Chelsea Mayoh, Pamela Ajuyah, et al. · Cancer Research
Abstract A001-PR009: Whole-genome-based, tumor-informed circulating tumor DNA detection correlates with treatment response and survival of pediatric solid tumor
2025 · Loretta M.S. Lau, Rob Salomon, et al. · Cancer Research
Abstract B009: Individualized-tumor-informed panel approach enables ultra-sensitive ctDNA-based minimal residue disease monitoring for high-risk pediatric cancers
2024 · Rob Salomon, Wenhan Chen, et al. · Clinical Cancer Research
Additional file 2 of GRIDSS2: comprehensive characterisation of somatic structural variation using single breakend variants and structural variant phasing
2021 · Cameron, Daniel L., Baber, Jonathan, et al. · Figshare
Pan-cancer whole genome analyses of metastatic solid tumors
2019 · E. Cuppen, P. Priestley, et al. · Annals of Oncology
Works count: 21
Citation count: 1,678
H-index: 8
I10-index: 8
Year
Topic
Type